These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 20189501)
21. Drug interactions of H2-receptor antagonists involving cytochrome P450 (CYPs) enzymes: from the laboratory to the clinic. Rendić S Croat Med J; 1999 Sep; 40(3):357-67. PubMed ID: 10411963 [TBL] [Abstract][Full Text] [Related]
22. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review). Murray M Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046 [TBL] [Abstract][Full Text] [Related]
23. Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management. Rathbun RC; Liedtke MD Pharmaceutics; 2011 Oct; 3(4):745-81. PubMed ID: 24309307 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice. Deodhar M; Al Rihani SB; Arwood MJ; Darakjian L; Dow P; Turgeon J; Michaud V Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32899642 [TBL] [Abstract][Full Text] [Related]
26. Chromosome-scale assembly and population diversity analyses provide insights into the evolution of Sapindus mukorossi. Xue T; Chen D; Zhang T; Chen Y; Fan H; Huang Y; Zhong Q; Li B Hortic Res; 2022 Jan; 9():. PubMed ID: 35178562 [TBL] [Abstract][Full Text] [Related]
27. A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death. Mesgarpour B; Gouya G; Herkner H; Reichardt B; Wolzt M Lipids Health Dis; 2015 Oct; 14():131. PubMed ID: 26497728 [TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450 eicosanoids in hypertension and renal disease. Fan F; Muroya Y; Roman RJ Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):37-46. PubMed ID: 25427230 [TBL] [Abstract][Full Text] [Related]
29. Use of antiarrhythmic drugs in elderly patients. Lee HC; Tl Huang K; Shen WK J Geriatr Cardiol; 2011 Sep; 8(3):184-94. PubMed ID: 22783304 [TBL] [Abstract][Full Text] [Related]
30. Cytochrome P450-mediated drug interactions. Flockhart DA; Oesterheld JR Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):43-76. PubMed ID: 10674190 [TBL] [Abstract][Full Text] [Related]
34. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs. Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550 [TBL] [Abstract][Full Text] [Related]
35. Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions. Lee MD; Ayanoglu E; Gong L Xenobiotica; 2006; 36(10-11):1013-80. PubMed ID: 17118918 [TBL] [Abstract][Full Text] [Related]